Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2019 Jan 16

PMID 30642013

Citations 24

Authors

Elena Gianchecchi

Alessandra Fierabracci

Affiliations

Soon will be listed here.

Abstract

Autoimmune disorders derive from genetic, stochastic, and environmental factors that all together interact in genetically predisposed individuals. The impact of an imbalanced gut microbiome in the pathogenesis of autoimmunity has been suggested by an increasing amount of experimental evidence, both in animal models and humans. Several physiological mechanisms, including the establishment of immune homeostasis, are influenced by commensal microbiota in the gut. An altered microbiota composition produces effects in the gut immune system, including defective tolerance to food antigens, intestinal inflammation, and enhanced gut permeability. In particular, early findings reported differences in the intestinal microbiome of subjects affected by several autoimmune conditions, including prediabetes or overt disease compared to healthy individuals. The present review focuses on microbiota-host homeostasis, its alterations, factors that influence its composition, and putative involvement in the development of autoimmune disorders. In the light of the existing literature, future studies are necessary to clarify the role played by microbiota modifications in the processes that cause enhanced gut permeability and molecular mechanisms responsible for autoimmunity onset.

Citing Articles

Pesticide use and inflammatory bowel disease in licensed pesticide applicators and spouses in the Agricultural Health Study.

Chen D, Parks C, Hofmann J, Beane Freeman L, Sandler D Environ Res. 2024; 249:118464.

PMID: 38354883 PMC: 11065595. DOI: 10.1016/j.envres.2024.118464.

Gut microbiota and eye diseases: a bibliometric study and visualization analysis.

Fu X, Tan H, Huang L, Chen W, Ren X, Chen D Front Cell Infect Microbiol. 2023; 13:1225859.

PMID: 37621873 PMC: 10445766. DOI: 10.3389/fcimb.2023.1225859.

Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes.

Bertuccio M, Rizzo V, Arena S, Trainito A, Montalto A, Caccamo D Curr Issues Mol Biol. 2023; 45(2):1333-1348.

PMID: 36826032 PMC: 9955553. DOI: 10.3390/cimb45020087.

The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models-An Overview.

Marin G, Neag M, Burlacu C, Buzoianu A Microorganisms. 2022; 10(10).

PMID: 36296329 PMC: 9608860. DOI: 10.3390/microorganisms10102053.

Gut microbiota development in the growing dog: A dynamic process influenced by maternal, environmental and host factors.

Garrigues Q, Apper E, Chastant S, Mila H Front Vet Sci. 2022; 9:964649.

PMID: 36118341 PMC: 9478664. DOI: 10.3389/fvets.2022.964649.

References

Hildebrand F, Nguyen T, Brinkman B, Garcia Yunta R, Cauwe B, Vandenabeele P . Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol. 2013; 14(1):R4. PMC: 4053703. DOI: 10.1186/gb-2013-14-1-r4. View

Stechova K, Kolar M, Blatny R, Halbhuber Z, Vcelakova J, Hubackova M . Healthy first-degree relatives of patients with type 1 diabetes exhibit significant differences in basal gene expression pattern of immunocompetent cells compared to controls: expression pattern as predeterminant of autoimmune diabetes. Scand J Immunol. 2011; 75(2):210-9. DOI: 10.1111/j.1365-3083.2011.02637.x. View

Loesche M, Farahi K, Capone K, Fakharzadeh S, Blauvelt A, Callis Duffin K . Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial. J Invest Dermatol. 2018; 138(9):1973-1981. DOI: 10.1016/j.jid.2018.03.1501. View

Chen J, Wright K, Davis J, Jeraldo P, Marietta E, Murray J . An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016; 8(1):43. PMC: 4840970. DOI: 10.1186/s13073-016-0299-7. View

Cox L, Cho I, Young S, Anderson W, Waters B, Hung S . The nonfermentable dietary fiber hydroxypropyl methylcellulose modulates intestinal microbiota. FASEB J. 2012; 27(2):692-702. PMC: 3545536. DOI: 10.1096/fj.12-219477. View

Clarke G, Stilling R, Kennedy P, Stanton C, Cryan J, Dinan T . Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014; 28(8):1221-38. PMC: 5414803. DOI: 10.1210/me.2014-1108. View

Mejia-Leon M, Petrosino J, Ajami N, Dominguez-Bello M, Calderon de la Barca A . Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci Rep. 2014; 4:3814. PMC: 3898044. DOI: 10.1038/srep03814. View

Brugman S, Klatter F, Visser J, Wildeboer-Veloo A, Harmsen H, Rozing J . Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia. 2006; 49(9):2105-8. DOI: 10.1007/s00125-006-0334-0. View

Gianchecchi E, Fierabracci A . On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota. Immunol Res. 2016; 65(1):242-256. DOI: 10.1007/s12026-016-8832-8. View

10.

Zenewicz L, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, Flavell R . Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008; 29(6):947-57. PMC: 3269819. DOI: 10.1016/j.immuni.2008.11.003. View

11.

Song H, Yoo Y, Hwang J, Na Y, Kim H . Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol. 2015; 137(3):852-60. DOI: 10.1016/j.jaci.2015.08.021. View

12.

Barbeau W . What is the key environmental trigger in type 1 diabetes--is it viruses, or wheat gluten, or both?. Autoimmun Rev. 2012; 12(2):295-9. DOI: 10.1016/j.autrev.2012.05.003. View

13.

Berer K, Gerdes L, Cekanaviciute E, Jia X, Xiao L, Xia Z . Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2017; 114(40):10719-10724. PMC: 5635914. DOI: 10.1073/pnas.1711233114. View

14.

Alekseyenko A, Perez-Perez G, De Souza A, Strober B, Gao Z, Bihan M . Community differentiation of the cutaneous microbiota in psoriasis. Microbiome. 2014; 1(1):31. PMC: 4177411. DOI: 10.1186/2049-2618-1-31. View

15.

Pinto E, Anselmo M, Calha M, Bottrill A, Duarte I, Andrew P . The intestinal proteome of diabetic and control children is enriched with different microbial and host proteins. Microbiology (Reading). 2017; 163(2):161-174. DOI: 10.1099/mic.0.000412. View

16.

Correa J, Calderaro D, Ferreira G, Mendonca S, Fernandes G, Xiao E . Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome. 2017; 5(1):34. PMC: 5359961. DOI: 10.1186/s40168-017-0252-z. View

17.

Lotti T, DErme A . Vitiligo as a systemic disease. Clin Dermatol. 2014; 32(3):430-4. DOI: 10.1016/j.clindermatol.2013.11.011. View

18.

Nestle F, Kaplan D, Barker J . Psoriasis. N Engl J Med. 2009; 361(5):496-509. DOI: 10.1056/NEJMra0804595. View

19.

. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

20.

Livanos A, Greiner T, Vangay P, Pathmasiri W, Stewart D, McRitchie S . Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat Microbiol. 2016; 1(11):16140. PMC: 5808443. DOI: 10.1038/nmicrobiol.2016.140. View